⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adcetris

Every month we try and update this database with for adcetris cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)NCT02169505
Lymphoma
Brentuximab Ved...
18 Years - 65 YearsM.D. Anderson Cancer Center
Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)NCT02096042
Leukemia
Brentuximab Ved...
5-Azacytidine
18 Years - M.D. Anderson Cancer Center
Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell LymphomasNCT03205891
Malignant Neopl...
Classical Hodgk...
Anaplastic Larg...
CD30+ Periphera...
Brentuximab Ved...
TAK228
Glucose Monitor
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: